Quarterly Transactions Made in Aerovate Therapeutics, Inc. (AVTE)
This table provides information about the institutional ownership of Aerovate Therapeutics, Inc. (AVTE). The information is specifically focused on institutions that hold shares of Aerovate Therapeutics, Inc..
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 223,779 | 1,831,749 | 2,055,528 | 337,058 | 50,515 | 387,573 | 1,667,955 | |
| Q4 2021 | 528,944 | 4,941,252 | 5,470,196 | 585,597 | 781,701 | 1,367,298 | 4,102,898 | |
| Q1 2022 | 400,205 | 377,895 | 778,100 | 105,100 | 277,266 | 382,366 | 395,734 | |
| Q2 2022 | 647,708 | 87,636 | 735,344 | 1,036,956 | 18,411 | 1,055,367 | -320,023 | |
| Q3 2022 | 1,733,326 | 523,719 | 2,257,045 | 568,887 | 0 | 568,887 | 1,688,158 | |
| Q4 2022 | 293,552 | 1,861,805 | 2,155,357 | 1,275,033 | 0 | 1,275,033 | 880,324 | |
| Q1 2023 | 912,800 | 406,202 | 1,319,002 | 817,761 | 0 | 817,761 | 501,241 | |
| Q2 2023 | 2,259,357 | 1,505,277 | 3,764,634 | 84,157 | 0 | 84,157 | 3,680,477 | |
| Q3 2023 | 599,331 | 100,000 | 699,331 | 289,572 | 0 | 289,572 | 409,759 | |
| Q4 2023 | 331,442 | 9,393,037 | 9,724,479 | 1,095,422 | 0 | 1,095,422 | 8,629,057 | |
| Q1 2024 | 685,692 | 1,124,704 | 1,810,396 | 902,317 | 0 | 902,317 | 908,079 | |
| Q2 2024 | 2,397,460 | 13,128,748 | 15,526,208 | 1,838,790 | 5,228 | 1,844,018 | 13,682,190 | |
| Q3 2024 | 1,781,803 | 1,022,934 | 2,804,737 | 1,100,652 | 0 | 1,100,652 | 1,704,085 | |